Adjuvant effect of biodegradable poly(DL-lactic acid) granules capable for antigen release following intraperitoneal injection

Vaccine

Volumn 14, Issue 17-18, 1996, Pages 1671-1676

  Nakaoka, Ryusuke ^a   Tabata, Yasuhiko ^a   Ikada, Yoshito ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

antibody production; antigen release; biodegradable granules; poly(DL lactic acid); release profile

Indexed keywords

LACTIC ACID; OVALBUMIN; VACCINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; BIODEGRADATION; CONTROLLED STUDY; DRUG GRANULE; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; BIODEGRADATION, ENVIRONMENTAL; HYDROGEL; INJECTIONS, INTRAPERITONEAL; LACTIC ACID; MICE; OVALBUMIN; POLYETHYLENE GLYCOLS; POLYMERS; POLYVINYL ALCOHOL; STEREOISOMERISM;

EID: 0030469429     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00098-9     Document Type: Article

References (25)

1. 1 Sander, L.M., McRae, G.I., Vitale, K.M. and Kell, B.A. Controlled delivery of a LHRH analogue from biodegradable injectable microspheres. J. Controlled Rel. 1984, 2, 178-185
2. 2 Keong, A.K., Chou, S., Sun, A.M., Sefton, M.V. and Goosen, M.F.A. In vitro and in vivo release of insulin from poly(lactic acid) microbeads and pellets. J. Controlled Rel. 1986, 4, 47-62
3. 3 Maulding, H.V. Prolonged delivery of peptides by microcapsule. J. Controlled Rel. 1987, 6, 167-176
4. 4 Okada, H., Heya, T., Igara, Y., Ogawa, Y., Togichi, H. and Shimamoto, T. One-month release injectable microspheres of leuprolide acetate inhibit steroidgenesis and genital organ growth in rats. Int. J. Pharm. 1989, 54, 231-239
5. 5 Hora, M.S., Rana, R.K., Nunberg, J.H., Tice, T.R., Gilley, R.M. and Hudson, M.E. Release of human serum albumin from poly(lactide-co-glycolide) microspheres. Pharm. Res. 1990, 7, 1190-1194
6. 6 Johnson, R.E., Lanaski, L.A., Gupta, V. et al. Stability of atriopeptin III in poly(DL-lactide-co-glycolide) microspheres. J. Controlled Rel. 1991, 17, 61-68
7. 7 Eppstein, D.A., van der Pas, M.A., Schryver, B.B., Felger, P.L., Gloff, C.A. and Soike, K.F. Controlled-release and localized targeting of interferon. In: Delivery Systems for Peptide Drugs (Eds Davis, S.S., Illum, L. and Tomlinson, E.). Plenum Press, New York, 1986, pp. 277-283
8. 8 Sanders, L.M., Kell, B.A., McRae, G.I. and Whitehead, G.W. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymers. J. Pharm. Sci. 1986, 75, 356-360
9. 9 Langer, R. New methods of drug delivery. Science 1990, 249, 1527-1533
10. 10 Kreuter, J. Nanoparticle-based drug delivery systems. J. Controlled Rel. 1991, 16, 169-176
11. 11 Alonso, M.J., Gupta, R.K., Min, C., Siber, G.R. and Langer, R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 1994, 12, 299-306
12. 12 McGee, J.P., Davis, S.S. and O'Hagen, D.T. The immunogenicity of a model protein entrapped in poly(lactide-co-glycolide) microspheres prepared by a novel phase separation technique. J. Controlled Rel. 1994, 31, 55-60
13. 13 Eldridge, J.H., Staas, J.K., Chen, D., Marx, P.A., Tice, T.R. and Gilley, R.M. New advances in vaccine delivery systems. Sem. Hematol. 1993, 304 Suppl. 4, 16-25
14. 14 Morris, W., Steinhoff, M.C. and Russell, P.K. Potential of polymer microencapsulation technology for vaccine innovation. Vaccine 1994, 12, 5-11
15. 15 Eppstein, D.A., Byars, N.E. and Allison, A.C. New adjuvants for vaccines containing purified protein antigens. Adv. Drug Del. Rev. 1990, 4, 233-253
16. 16 Eldridge, J.H., Hammond, C.J., Meulbroek, J.A., Staas, J.K., Gilley, R.M. and Tice, T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches. J. Controlled Rel. 1990, 11, 205-214
17. 17 Almeida, A.J., Alpar, H.O. and Brown, M.R.W. Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs. J. Pharm. Pharmac. 1993, 45, 198-203
18. 18 Eldridge, J.H., Staas, J.K., Meulbroek, J.A., Tice, T.R. and Gilley, R.M. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies. Infect. Immun. 1991, 59, 2978-2986
19. 19 Tabata, Y. and Ikada, Y. Macrophage phagocytosis of biodegradable microspheres composed of L-lactic/glycolic acid homo- and copolymers. J. Biomed. Mater. Res. 1988, 22, 837-858
20. 20 Tabata, Y., Takebayashi, Y., Ueda, T. and Ikada, Y. A formulation method using D,L-lactic acid oligomer for protein release with reduced initial burst. J. Controlled Rel. 1993, 23, 55-64
21. 21 McGrath, R. Protein measurement by the ninhydrin determination of amino acids released by alkaline hydrolysis. Analyt. Biochem. 1972, 49, 95-102
22. 22 Inoue, K., Fujisato, T., Gu, Y.J. et al. Experimental hybrid islet transplantation: application of polyvinyl alcohol membrane for entrappment of islets. Pancreas 1992, 7, 562-568
23. 23 Nakaoka, R., Tabata, Y. and Ikada, Y. Potentiality of gelatin microsphere as immunological adjuvant. Vaccine 1995, 13, 653-661
24. 24 Nakaoka, R., Tabata, Y. and Ikada, Y. Enhanced antibody production through sustained antigen release from biodegradable granules. J. Controlled Rel. 1995, 37, 215-224
25. 25 Burczak, K., Fujisato, T., Hatada, M. and Ikada, Y. Protein permeation through poly(vinyl alcohol) hydrogel membranes. Biomaterials 1994, 15, 231-238